Episode details

Available for over a year
The 'pink pill' flibanserin has been called 'the female Viagra', but critics argue its benefits are few and side effects many. Melanie Abbott investigates how the failed anti-depressant came to be licensed in the USA, and what the future plans are to bring the drug to Europe. Presenter: Melanie Abbott Producer: James Melley Researcher: Phoebe Keane.
Programme Website